These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20754618)

  • 41. Renal PGE2 production in the human and rat following phenacetin, acetaminophen and p-aminophenol.
    Goodin MG; Walker RJ; Rosengren RJ
    Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):153-66. PubMed ID: 14632321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.
    Veronese ME; McLean S
    Eur J Clin Pharmacol; 1991; 40(6):547-52. PubMed ID: 1884734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acetaminophen production in man after coadministration of acetanilid and phenacetin. A study with stable isotopes.
    Baty JD; Robinson PR
    Clin Pharmacol Ther; 1977 Feb; 21(2):177-86. PubMed ID: 837636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IRMS to study a common cocaine cutting agent: phenacetin.
    Ladroue V; Dujourdy L; Besacier F; Jame P
    Drug Test Anal; 2017 Mar; 9(3):479-484. PubMed ID: 27860349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hypernephroid carcinoma and carcinoma of the urinary tract following phenacetin abuse].
    Küng LG
    Schweiz Med Wochenschr; 1976 Jan; 106(2):47-51. PubMed ID: 1257713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Addenda to our knowledge on the pathogenesis of toxico-hemolytic anemia following the administration of phenacetin (saridon)].
    JASINSKI B
    Schweiz Med Wochenschr; 1950 Oct; 80(41):1113-4. PubMed ID: 14787386
    [No Abstract]   [Full Text] [Related]  

  • 47. Suppression of phenacetin-induced methemoglobinemia by diethyldithiocarbamate and carbon disulfide and its relation to phenacetin metabolism in mice.
    Nakayama N; Masuda Y
    J Pharmacobiodyn; 1985 Oct; 8(10):868-76. PubMed ID: 3005542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis.
    Stewart JH; Hobbs JB; McCredie MR
    Cancer; 1999 Oct; 86(8):1576-82. PubMed ID: 10526288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assay of phenacetin genotoxicity using in vitro and in vivo test systems.
    De Flora S; Russo P; Pala M; Fassina G; Zunino A; Bennicelli C; Zanacchi P; Camoirano A; Parodi S
    J Toxicol Environ Health; 1985; 16(3-4):355-77. PubMed ID: 3910846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Demonstration of paracetamol in the urine following ingestion of therapeutic doses of phenacetin-containing analgesics].
    Goenechea S
    Z Klin Chem Klin Biochem; 1969 Jul; 7(4):346-9. PubMed ID: 5357653
    [No Abstract]   [Full Text] [Related]  

  • 51. Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants.
    Yun CH; Miller GP; Guengerich FP
    Biochemistry; 2000 Sep; 39(37):11319-29. PubMed ID: 10985777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia.
    Kobayashi Y; Fukami T; Higuchi R; Nakajima M; Yokoi T
    Biochem Pharmacol; 2012 Nov; 84(9):1196-206. PubMed ID: 22940574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formation of reactive metabolites of phenacetin in humans and rats.
    Veronese ME; McLean S; D'Souza CA; Davies NW
    Xenobiotica; 1985 Nov; 15(11):929-40. PubMed ID: 4082633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analgesic nephropathy: removal of phenacetin from proprietary analgesics.
    Murray RM
    Br Med J; 1972 Oct; 4(5833):131-2. PubMed ID: 5078444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of transcatheter arterial chemoembolization on CYP1A2 activity in patients with hepatocellular carcinoma.
    Huang W; Qu ZQ; Li XD; He P; Ding N; Zhang SL; Wu MC
    J Clin Pharm Ther; 2008 Oct; 33(5):489-93. PubMed ID: 18834363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MORPHOLOGIC CHANGES IN THE KIDNEYS OF RATS FOLLOWING PROLONGED ADMINISTRATION OF PHENACETIN.
    PRZYBYL L; CHODERA A; MAJEWSKI C; BADYDA C
    Arch Immunol Ther Exp (Warsz); 1964; 12():628-34. PubMed ID: 14252043
    [No Abstract]   [Full Text] [Related]  

  • 57. Temporal variations in acetaminophen and phenacetin half-life in man.
    Shively CA; Vesell ES
    Clin Pharmacol Ther; 1975 Oct; 18(4):413-24. PubMed ID: 1100307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenacetin O-deethylation is a useful tool for evaluation of hepatic functional reserve in rats with CCl(4)-induced chronic liver injury.
    Liu Z; Qu Z; Li X; Cai M; He P; Zhou M; Xiao J; Wang X
    J Surg Res; 2012 Jun; 175(2):e61-6. PubMed ID: 22341342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accuracy of death certificates in bronchial asthma. Accuracy of certification procedures during the confidential inquiry by the British Thoracic Association. A subcommittee of the BTA Research Committee.
    Thorax; 1984 Jul; 39(7):505-9. PubMed ID: 6463930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen.
    Watanabe A; Fukami T; Takahashi S; Kobayashi Y; Nakagawa N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2010 Sep; 38(9):1532-7. PubMed ID: 20542992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.